Apimeds Pharmaceuticals US, Inc. (APUS) short interest & options flow
AMEXAPUS cost to borrow surges to 27.2%, up 111% in one week as short interest climbs 55% over the same period.
- Market cap
- $4M
Key data as of 12 Nov 2026

Latest signals on APUS
- Cost to Borrow
APUS cost to borrow surges to 27.2%, up 111% in one week as short interest climbs 55% over the same period.
- Short Interest
APUS short interest surges 55.5% in one week to 145,865 shares, as cost to borrow jumps 111% to 27.2%. Utilization eased to 49.1% from 65.6%.
APUS news and analysis
RSSNo long-form analysis yet for APUS. Pulse alerts and the live data picture are available on ORTEX.
Open APUS on ORTEX →Want the live picture for APUS?
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for APUS — free to start on ORTEX.
Sign up for free →Open APUS on ORTEX